Publications by authors named "Marissa Herrman"

Claim this Profile
A
ADI-270: an armored allogeneic gamma delta T cell therapy designed to target CD70-expressing solid and hematologic malignancies.
Kevin P Nishimoto, Gauri Lamture, Yvan Chanthery, Alexander G Teague, Yogendra Verma, Marissa Herrman

J Immunother Cancer· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Allogeneic CD20-targeted γδ T cells exhibit innate and adaptive antitumor activities in preclinical B-cell lymphoma models.
Kevin P Nishimoto, Taylor Barca, Aruna Azameera, Amani Makkouk, Jason M Romero, Marissa Herrman

Clin Transl Immunology· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Off-the-shelf Vδ1 gamma delta T cells engineered with glypican-3 (GPC-3)-specific chimeric antigen receptor (CAR) and soluble IL-15 display robust antitumor efficacy against hepatocellular carcinoma.
Amani Makkouk, Xue Cher Yang, Taylor Barca, Anthony Lucas, Mustafa Turkoz, Marissa Herrman

J Immunother Cancer· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Epstein-Barr Virus gp350 Can Functionally Replace the Rhesus Lymphocryptovirus Major Membrane Glycoprotein and Does Not Restrict Infection of Rhesus Macaques.
Marissa Herrman, Janine Mühe, Carol Quink, Fred Wang

J Virol· February 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis